khaldan ayoub (59 risultati)

Condizione: New.

Taschenbuch. Condizione: Neu. Development of Novel Antileishmanial Drugs | Challenges and Recent Advances | Ayoub Khaldan (u. a.) | Taschenbuch | Englisch | 2023 | LAP LAMBERT Academic Publishing | EAN 9786206738121 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Condizione: New.

Taschenbuch. Condizione: Neu. Nueva ¿-Glucosidasa como Inhibidores Antidiabéticos: Enfoques in silico | Ayoub Khaldan (u. a.) | Taschenbuch | Spanisch | 2023 | Ediciones Nuestro Conocimiento | EAN 9786206907190 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Développement de nouveaux médicaments antiishmaniens | Défis et avancées récentes | Ayoub Khaldan (u. a.) | Taschenbuch | Französisch | 2023 | Editions Notre Savoir | EAN 9786206307778 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Condizione: New.

Taschenbuch. Condizione: Neu. Nouvelles ¿-Glucosidases en tant qu'inhibiteurs antidiabétiques : Approches in silico | Ayoub Khaldan (u. a.) | Taschenbuch | Französisch | 2023 | Editions Notre Savoir | EAN 9786206907206 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Condizione: New.

Condizione: New.

Taschenbuch. Condizione: Neu. Desenvolvimento de novos medicamentos antileishmaniais | Desafios e avanços recentes | Ayoub Khaldan (u. a.) | Taschenbuch | Portugiesisch | 2023 | Edições Nosso Conhecimento | EAN 9786206307792 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Sviluppo di nuovi farmaci antileishmaniani | Sfide e progressi recenti | Ayoub Khaldan (u. a.) | Taschenbuch | Italienisch | 2023 | Edizioni Sapienza | EAN 9786206307785 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Condizione: New.

Condizione: New.

Taschenbuch. Condizione: Neu. Entwicklung neuartiger Antileishmania-Medikamente | Herausforderungen und jüngste Fortschritte | Ayoub Khaldan (u. a.) | Taschenbuch | 92 S. | Deutsch | 2023 | Verlag Unser Wissen | EAN 9786206307754 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Novas ¿-Glucosidase como inibidores antidiabéticos: Abordagens in silico | Ayoub Khaldan (u. a.) | Taschenbuch | Portugiesisch | 2023 | Edições Nosso Conhecimento | EAN 9786206907220 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Nuove ¿-Glucosidasi come inibitori antidiabetici: Approcci in silico | Ayoub Khaldan (u. a.) | Taschenbuch | Italienisch | 2023 | Edizioni Sapienza | EAN 9786206907213 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Condizione: Neu. Neue ¿-Glucosidase als antidiabetische Inhibitoren: In silico-Ansätze | Ayoub Khaldan (u. a.) | Taschenbuch | 96 S. | Deutsch | 2023 | Verlag Unser Wissen | EAN 9786206907183 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Condizione: New. Print on Demand.

Condizione: New. PRINT ON DEMAND.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Leishmaniasis is a vector-borne disease caused by the Leishmania parasites. It affects humans and other mammals and is transmitted through the bites of infected female sandflies. The disease is found in different parts of the world, including Africa, Asia, Europe and the Americas, with varying degrees of prevalence depending on the region. In Morocco, zoonotic cutaneous leishmaniasis caused by Leishmania major is known to cause sporadic and unpredictable epidemics, particularly in the southern and southeastern regions of the country. Until now, there is no vaccine or prophylactic drug for leishmaniasis. Drug repositioning is the only means to combat this disease. Miltefosine, pentamidine and sitamaquine are the main drugs used to treat leishmaniasis. Some side effects, such as oral administration problems, severe injection site pain, cardiac and renal toxicities and gastrointestinal abnormalities, are medically noted during the treatment protocol. Consequently, the development of powerful, safer and less expensive new drugs has become the most important challenge facing the world today. 80 pp. Englisch.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 88 pp. Spanisch.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Leishmaniasis is a vector-borne disease caused by the Leishmania parasites. It affects humans and other mammals and is transmitted through the bites of infected female sandflies. The disease is found in different parts of the world, including Africa, Asia, .

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -La leishmaniose est une maladie à transmission vectorielle causée par les parasites Leishmania. Elle affecte les humains et d'autres mammifères et se transmet par les piqûres de phlébotomes femelles infectées. La maladie se trouve dans différentes parties du monde, y compris l'Afrique, l'Asie, l'Europe et les Amériques, avec des degrés de prévalence variables selon la région. Au Maroc, la leishmaniose cutanée zoonotique causée par Leishmania major est connue pour provoquer des épidémies sporadiques et imprévisibles, en particulier dans les régions du sud et du sud-est du pays. Jusqu'à présent, il n'existe aucun vaccin ou médicament prophylactique contre la leishmaniose. Le repositionnement des médicaments est le seul moyen de lutter contre cette maladie. La miltéfosine, la pentamidine et la sitamaquine sont les principaux médicaments utilisés pour traiter la leishmaniose. Certains effets secondaires, tels que des problèmes d'administration orale, des douleurs sévères au site d'injection, des toxicités cardiaques et rénales et des anomalies gastro-intestinales, sont notés médicalement au cours du protocole de traitement. Par conséquent, le développement de nouveaux médicaments puissants, plus sûrs et moins coûteux est devenu le défi le plus important auquel le monde est confronté aujourd'hui. 92 pp. Französisch.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In this book, different Computer Aided Drug Design (CADD) methods were used to design new inhibitors that can be used to treat diabetes disease. 3-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) and molecular docking approaches were applied to discover and rationalize novel bioactive nitrogen-containing heterocyclic molecules as new -glucosidase inhibitors. In addition, Lipinski's rule of five and ADME/Tox pharmacokinetics were also used to assess the oral bioavailability and study the toxicity of newly designed molecules. All in silico methods show promising results as anti-diabetic candidate drugs. Also, no chemical similarity between the designed compounds and the drugs used and studied in the literature or databases. Therefore, the results obtained in this book encourage further experimental and scientific studies of newly designed compounds, which could be anti-diabetic agents with high inhibitory potency. We will focus our discussion in this book on the many interesting scientific articles published by our research group in a number of reputed national and international journals. 124 pp. Englisch.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Leishmaniasis is a vector-borne disease caused by the Leishmania parasites. It affects humans and other mammals and is transmitted through the bites of infected female sandflies. The disease is found in different parts of the world, including Africa, Asia, Europe and the Americas, with varying degrees of prevalence depending on the region. In Morocco, zoonotic cutaneous leishmaniasis caused by Leishmania major is known to cause sporadic and unpredictable epidemics, particularly in the southern and southeastern regions of the country. Until now, there is no vaccine or prophylactic drug for leishmaniasis. Drug repositioning is the only means to combat this disease. Miltefosine, pentamidine and sitamaquine are the main drugs used to treat leishmaniasis. Some side effects, such as oral administration problems, severe injection site pain, cardiac and renal toxicities and gastrointestinal abnormalities, are medically noted during the treatment protocol. Consequently, the development of powerful, safer and less expensive new drugs has become the most important challenge facing the world today.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 80 pp. Englisch.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Leishmaniasis is a vector-borne disease caused by the Leishmania parasites. It affects humans and other mammals and is transmitted through the bites of infected female sandflies. The disease is found in different parts of the world, including Africa, Asia, Europe and the Americas, with varying degrees of prevalence depending on the region. In Morocco, zoonotic cutaneous leishmaniasis caused by Leishmania major is known to cause sporadic and unpredictable epidemics, particularly in the southern and southeastern regions of the country. Until now, there is no vaccine or prophylactic drug for leishmaniasis. Drug repositioning is the only means to combat this disease. Miltefosine, pentamidine and sitamaquine are the main drugs used to treat leishmaniasis. Some side effects, such as oral administration problems, severe injection site pain, cardiac and renal toxicities and gastrointestinal abnormalities, are medically noted during the treatment protocol. Consequently, the development of powerful, safer and less expensive new drugs has become the most important challenge facing the world today.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Khaldan AyoubDr. Ayoub Khaldan holds a PhD in chemistry from Moulay Ismail University of Meknes, Morocco. Dr. Ayoub Khaldan is a secondary school Physical Chemistry teacher. He has published a number of research articles in various r.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In this book, different Computer Aided Drug Design (CADD) methods were used to design new inhibitors that can be used to treat diabetes disease. 3-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) and molecular docking approaches were applied to discover and rationalize novel bioactive nitrogen-containing heterocyclic molecules as new ¿-glucosidase inhibitors. In addition, Lipinski's rule of five and ADME/Tox pharmacokinetics were also used to assess the oral bioavailability and study the toxicity of newly designed molecules. All in silico methods show promising results as anti-diabetic candidate drugs. Also, no chemical similarity between the designed compounds and the drugs used and studied in the literature or databases. Therefore, the results obtained in this book encourage further experimental and scientific studies of newly designed compounds, which could be anti-diabetic agents with high inhibitory potency. We will focus our discussion in this book on the many interesting scientific articles published by our research group in a number of reputed national and international journals.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 124 pp. Englisch.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In this book, different Computer Aided Drug Design (CADD) methods were used to design new inhibitors that can be used to treat diabetes disease. 3-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) and molecular docking approaches were applied to discover and rationalize novel bioactive nitrogen-containing heterocyclic molecules as new -glucosidase inhibitors. In addition, Lipinski's rule of five and ADME/Tox pharmacokinetics were also used to assess the oral bioavailability and study the toxicity of newly designed molecules. All in silico methods show promising results as anti-diabetic candidate drugs. Also, no chemical similarity between the designed compounds and the drugs used and studied in the literature or databases. Therefore, the results obtained in this book encourage further experimental and scientific studies of newly designed compounds, which could be anti-diabetic agents with high inhibitory potency. We will focus our discussion in this book on the many interesting scientific articles published by our research group in a number of reputed national and international journals.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 96 pp. Spanisch.